MetLife Investment Management’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,630
Closed -$71K 2505
2021
Q1
$71K Sell
4,630
-7,690
-62% -$125K ﹤0.01% 2271
2020
Q4
$199K Hold
12,320
﹤0.01% 1987
2020
Q3
$172K Hold
12,320
﹤0.01% 1946
2020
Q2
$262K Buy
12,320
+3,904
+46% +$69K ﹤0.01% 1739
2020
Q1
$139K Buy
+8,416
New +$153K ﹤0.01% 1886

Other funds holding BCEL

MetLife Investment Management's BCEL Position: Q2 2021 in Review

MetLife Investment Management sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2021, closing a stake of 4,630 shares — an estimated $71K sold.

MetLife Investment Management first reported a position in BCEL in Q1 2020 and held it in 5 quarters. The position peaked at $262K in Q2 2020. 108 funds tracked by Wall St. Rank hold BCEL as of Q2 2021.

  • MetLife Investment Management reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • MetLife Investment Management sold 4,630 Atreca, Inc. Class A Common Stock shares in Q2 2021, an estimated $71K.
  • MetLife Investment Management first reported a position in Atreca, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
  • MetLife Investment Management's Atreca, Inc. Class A Common Stock position peaked at $262K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2021.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.